换一批
第一作者：
Martin,Dreyling
第一单位：
Department of Medicine III, LMU Hospital, Munich, Germany.
作者：
Martin,Dreyling [1]
;
Marc,André [2]
;
Nicola,Gökbuget [3]
;
Hervé,Tilly [4]
;
Mats,Jerkeman [5]
;
John,Gribben [6]
;
Andrés,Ferreri [7]
;
Pierre,Morel [8]
;
Stephan,Stilgenbauer [9]
;
Christopher,Fox [10]
;
José,Maria Ribera [11]
;
Sonja,Zweegman [12]
;
Igor,Aurer [13]
;
Csaba,Bödör [14]
;
Birgit,Burkhardt [15]
;
Christian,Buske [16]
;
Maria,Dollores Caballero [17]
;
Elias,Campo [18]
;
Bjoern,Chapuy [19]
;
Andrew,Davies [20]
;
Laurence,de Leval [21]
;
Jeanette,Doorduijn [22]
;
Massimo,Federico [23]
;
Philippe,Gaulard [24]
;
Francesca,Gay [25]
;
Paolo,Ghia [26]
;
Kirsten,Grønbæk [27]
;
Hartmut,Goldschmidt [28]
;
Marie-Jose,Kersten [29]
;
Barbara,Kiesewetter [30]
;
Judith,Landman-Parker [31]
;
Steven,Le Gouill [32]
;
Georg,Lenz [33]
;
Sirpa,Leppä [34]
;
Armando,Lopez-Guillermo [35]
;
Elizabeth,Macintyre [36]
;
Maria Victoria Mateos,Mantega [37]
;
Philippe,Moreau [38]
;
Carol,Moreno [39]
;
Bertrand,Nadel [40]
;
Jessica,Okosun [41]
;
Roger,Owen [42]
;
Sarka,Pospisilova [43]
;
Christiane,Pott [44]
;
Tadeusz,Robak [45]
;
Michelle,Spina [46]
;
Kostas,Stamatopoulos [47]
;
Jan,Stary [48]
;
Karin,Tarte [49]
;
Allessandra,Tedeschi [50]
;
Catherine,Thieblemont [51]
;
Ralf Ulrich,Trappe [52]
;
Lorenz H,Trümper [53]
;
Gilles,Salles [54]
作者单位：
Department of Medicine III, LMU Hospital, Munich, Germany.
[1]
Université Catholique de Louvain, CHU UcL Namur, Yvoir, Belgium.
[2]
Department of Medicine II, Hematology/Oncology, University Hospital Frankfurt, Goethe University, Frankfurt, Germany.
[3]
INSERM U1245, Department of Hematology, Centre Henri Becquerel and Université de Rouen, France.
[4]
Skåne University and Lund University, Lund, Sweden.
[5]
Barts Cancer Institute, Queen Mary University of London, United Kingdom.
[6]
Lymphoma Unit, Department of Onco-hematology, IRCCS San Raffaele Scientific Institute, Milano, Italy.
[7]
Service Hematologie Clinique Therapie Cellulaire, CHU Amiens Picardie, Amiens, France.
[8]
Comprehensive Cancer Center Ulm (CCCU), Sektion CLL Klinik für Innere Medizin III, Universität Ulm, Germany.
[9]
School of Medicine, University of Nottingham, United Kingdom.
[10]
Clinical Hematology Department, ICO-Hospital Germans Trias i Pujol, Josep Carreras Research Institute, Badalona, Spain.
[11]
Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, the Netherlands.
[12]
University Hospital Centre Zagreb and Medical School, University of Zagreb, Croatia.
[13]
HCEMM-SE Molecular Oncohematology Research Group, Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
[14]
Experimentelle und Translationale päd. Hämatologie u Onkologie, Leitung der Bereiche Lymphome und Stammzelltransplantation, Universitätsklinikum Münster (UKM), Klinik für Kinder- und Jugendmedizin, Pädiatrische Hämatologie und Onkologie, Munich, Germany.
[15]
Institute of Experimental Cancer Research, CCC Ulm, University Hospital Ulm, Germany.
[16]
Clinical and Transplant Unit, University Hospital of Salamanca, Spain.;Department of Medicine at the University of Salamanca, Spain.;El Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain.
[17]
Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
[18]
Department of Hematology, Oncology and Tumor Immunology, Charité, University Medical Center Berlin, Campus Benjamin Franklin, Berlin, Germany.;Berlin Institute of Health, Berlin, Germany.
[19]
Southampton NCRI/UK Experimental Cancer Medicines Centre, Faculty of Medicine, University of Southampton, United Kingdom.
[20]
Department of Laboratory Medicine and Pathology, Institute of Pathology, Lausanne University Hospital and Lausanne University, Lausanne, Switzerland.
[21]
Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands.
[22]
Città di Lecce Hospital, GVM Care & Research, Lecce, Italy.
[23]
Département de Pathologie, Hôpital Henri Mondor, AP-HP, Créteil, France.
[24]
Clinical Trial Unit, Division of Hematology 1, AOU Città Della Salute e Della Scienza, University of Torino, Italy.
[25]
Università Vita Salute San Raffaele and IRCCS Ospedale San Raffaele, Milano, Italy.
[26]
Department of Hematology, Rigshospitalet, Copenhagen, Denmark.;Biotech Research & Innovation Centre (BRIC), University of Copenhagen, Denmark.
[27]
University Hospital Heidelberg, Internal Medicine V and National Center for Tumor Diseases (NCT), Heidelberg, Germany.
[28]
Department of Hematology, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam and LYMMCARE, Amsterdam, the Netherlands.
[29]
Department of Medicine I, Division of Oncology, Medical University of Vienna, Austria.
[30]
Pediatric Hematology Oncology, Sorbonne Université APHP/hôpital A Trousseau, Paris, France.
[31]
Service d'Hématologie, Clinique du Centre Hospitalier Universitaire (CHU) de Nantes, France.
[32]
Medical Department A for Hematology, Oncology and Pneumology, University Hospital Münster, Germany.
[33]
University of Helsinki and Helsinki University Hospital Comprehensive Cancer Centre, Helsinki, Finland.
[34]
Department of Hematology, Hospital Clínic de Barcelona, Spain.
[35]
Onco-hematology, Université de Paris and Necker-Enfants Malades Hospital, Assistance Publique-Hôpitaux de Paris, France.
[36]
Complejo Asistencial Universitario de Salamanca, IBSAL, CIC, Universidad de Salamanca, Ciberonc, Salamanca, Spain.
[37]
Hematology Department, University Hospital Hotel-Dieu, Nantes, France.
[38]
Hospital de la Santa Creu I Sant Pau, Autonomous University of Barcelona, Spain.
[39]
Aix Marseille Univ, CNRS, INSERM, CIML, Marseille, France.
[40]
Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, United Kingdom.
[41]
St James's Institute of Oncology, Leeds, United Kingdom.
[42]
Department of Internal Medicine-Hematology and Oncology and Department of Medical Genetics and Genomics, Faculty of Medicine, Masaryk University and University Hospital Brno, Czech Republic.
[43]
Klinisch-experimentelle Hämatologie, Medizinische Klinik II, Hämatologie und Internistische Onkologie, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Germany.
[44]
Medical University of Lodz, Poland.
[45]
Division of Medical Oncology and Immune-related Tumors, National Cancer Institute, Aviano, Italy.
[46]
Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece.
[47]
Department of Pediatric Hematology and Oncology 2nd Faculty of Medicine, Charles University Prague University Hospital, Prague, Czech Republic.
[48]
Immunology and Cell Therapy Lab at Rennes University Hospital, Rennes, France.
[49]
Department of Hematology, Niguarda Hospital Milano, Italy.
[50]
Department of Hemato-Oncology, Saint-Louis Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
[51]
Department of Internal Medicine II: Haematology and Oncology, DIAKO Hospital Bremen, Germany.
[52]
Hematology and Medical Oncology, University Medicine Goettingen, Germany.
[53]
Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine, New York, NY, USA.
[54]
DOI
10.1097/HS9.0000000000000726
PMID
35620592
发布时间
2024-08-30
基金项目
P30 CA008748/CA/NCI NIH HHS/United States
- 浏览1
HemaSphere
HemaSphere
2022年6卷6期
e726页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
